Mathematical multi-scale model of the cardiovascular system including mitral valve dynamics. Application to ischemic mitral insufficiency by Paeme, Sabine et al.
RESEARCH Open Access
Mathematical multi-scale model of the
cardiovascular system including mitral valve
dynamics. Application to ischemic mitral
insufficiency
Sabine Paeme
1*, Katherine T Moorhead
1, J Geoffrey Chase
2, Bernard Lambermont
1, Philippe Kolh
1, Vincent D’orio
1,
Luc Pierard
1, Marie Moonen
1, Patrizio Lancellotti
1, Pierre C Dauby
1 and Thomas Desaive
1
* Correspondence: sabine.
paeme@ulg.ac.be
1Cardiovascular Research Center,
University of Liege, Liege, Belgium
Full list of author information is
available at the end of the article
Abstract
Background: Valve dysfunction is a common cardiovascular pathology. Despite
significant clinical research, there is little formal study of how valve dysfunction
affects overall circulatory dynamics. Validated models would offer the ability to better
understand these dynamics and thus optimize diagnosis, as well as surgical and
other interventions.
Methods: A cardiovascular and circulatory system (CVS) model has already been
validated in silico, and in several animal model studies. It accounts for valve dynamics
using Heaviside functions to simulate a physiologically accurate “open on pressure,
close on flow” law. However, it does not consider real-time valve opening dynamics
and therefore does not fully capture valve dysfunction, particularly where the
dysfunction involves partial closure. This research describes an updated version of
this previous closed-loop CVS model that includes the progressive opening of the
mitral valve, and is defined over the full cardiac cycle.
Results: Simulations of the cardiovascular system with healthy mitral valve are
performed, and, the global hemodynamic behaviour is studied compared with
previously validated results. The error between resulting pressure-volume (PV) loops
of already validated CVS model and the new CVS model that includes the
progressive opening of the mitral valve is assessed and remains within typical
measurement error and variability. Simulations of ischemic mitral insufficiency are
also performed. Pressure-Volume loops, transmitral flow evolution and mitral valve
aperture area evolution follow reported measurements in shape, amplitude and
trends.
Conclusions: The resulting cardiovascular system model including mitral valve
dynamics provides a foundation for clinical validation and the study of valvular
dysfunction in vivo. The overall models and results could readily be generalised to
other cardiac valves.
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Mitral insufficiency (MI) is a frequent valvular pathology that develops as a result of
dysfunction or modification in one of the elements of the mitral valvular complex
(leaflets, tendinous chords, papillary muscles, left atrial wall or ventricular myocardium
located next to papillary muscles). During MI, blood in the left ventricle flows back
through the mitral valve towards the left atrium due to the loss of integrity of the
valve, and a loss of the atrio-ventricular pressure gradient during systole [1-3]. The
presence of a MI leads to a chronic overload in volume which is responsible for left
ventricular dilatation, which, in its turn, increases the mitral insufficiency [3].
Ischemic mitral insufficiency (IMI) results from a ventricular remodeling usually fol-
lowing myocardial infarction. It is observed in 15 to 30% of the patients after acute
myocardial infarction [4] and in 56% of the patients having a chronic left ventricular
systolic dysfunction (ejection fraction < 40%) [5]. IMI is a dynamic condition whereby
t h es e v e r i t yo ft h er e g u r g i t a t i o nc h a n g e swith time. This dynamic behavior can be
responsible for the non-detection of the insufficiency for certain patients at high risk
of morbidity and mortality [6,7]. Recent clinical studies have detected and quantified
this dynamic behavior using Doppler echography [3].
As it is well-known mathematical models of the cardiovascular system (CVS) offer a
promising method of assisting in understanding cardiovascular dysfunction, this
research propose such a model to study IMI.
Mathematical models of the CVS vary significantly in their complexity and their
objectives. They range from the simple Windkessel model [8], a zero-dimensional
model, to very complex network representations of the vascular tree [9] or even finite
element models of several million degrees of freedom [10,11]. All of them have differ-
ent uses or goals, but they all share the common goal of understanding non invasively
the cardiovascular function [12].
One example of low to intermediate complexity model, known as a “minimal cardiac
model”, has been developed and optimized [13-15] to assist health professionals in
selecting reliable and appropriate therapies for Intensive Care Unit (ICU) patients. It is
based on a “pressure-volume” (PV) lumped element modeling approach, the principle
of which is that the continuous variation of the system’s state variables in space is
represented by a finite number of variables, defined at special points called nodes [12].
The cardiovascular system is thus divided into several chambers described by their
own PV relationship [13,16]. The main advantage of this technique is that it only
requires a small number of parameters, allowing for easy and rapid simulations and for
patient-specific identification of disease state at the bedside with readily available clini-
cal data [17-19].
This model has been proven to provide reliable description of the global cardiac
function in several disease states such as pulmonary embolism and septic shock
[20,21]. However, it does not allow for the description of lower anatomical scales, such
as the valvular level.
The simplest description of the heart valve used in 0D CVS models represents the
valve as a diode plus a resistance [9,16,22-24]. This description assumes the ideal charac-
teristic of one-way flow in a heart valve, while more complex dynamics, such as regurgi-
tant flow, can’t be simulated. Žáček and Krause [25] used time dependent drag
coefficients in a way that valve closing is achieved by letting the drag coefficient
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prescribed instead of computed. An attempt to describe the progressive opening of the
mitral valve based on physical properties of the valve was made by Szabó et al.
[12,26-28]. However, their model is only valid during the early ventricular filling phase
also referred to as E-wave filling. As we want to keep the minimal model’s simplicity and
therapeutic use, we can’t use other valve models that are either too complex or/and do
not account for dynamics over a full cardiac cycle [29-31].
This paper presents a minimal closed-loop model of the CVS including a description
of the progressive opening and closing of the mitral valve at more refined scale. This
new multi-scale model is validated for a healthy mitral valve. The impact of the pro-
gressive opening and closing of the mitral valve on circulatory dynamics is analyzed,
with emphasis on IMI. Clinically, understanding this impact and the ability to identify
it from clinical data would lead directly to new model-based diagnostic capabilities.
Methods
This section first describes the existing and previously validated minimal model of the
cardiovascular system, on which our model is based. Then, it describes a model of the
mitral valve and its integration into the CSV model. Finally, methods used to analyse
and criticize the results are presented.
CVS model
The CVS model used to describe the cardiovascular system was first described by
S m i t he ta l[ 1 3 ]a n dh a sa l r e a d yb e e nv a l i d a t e din silico and in several animal model
studies [15,17,20,21,32,33]. It is a lumped parameter model consisting of six elastic
chambers, the left ventricle (lv), the right (rv) ventricle, the vena cava (vc), the aorta
(ao), the pulmonary artery (pa) and the pulmonary veins (pu), linked by vessels
presenting a resistance to the blood flow. The diagram of this model is presented in
Figure 1.
The systemic and pulmonary circulation networks are modelled by the resistances
Rsys and Rpul, respectively, while the cardiac valves are modeled by a resistance and a
diode that opens when the pressure upstream exceeds the pressure downstream and
Figure 1 Cardiovascular system model consisting of 6 cardiac chambers, vascular flow resistances,
on/off heart valves and including ventricular interaction. The 6 cardiac chambers are the left ventricle
(lv), the right (rv) ventricle, the vena cava (vc), the aorta (ao), the pulmonary artery (pa) and the pulmonary
veins (pu). Systemic and pulmonary circulation flow resistances are Rsys and Rpul. The cardiac valves are
modeled by a resistance (Rmt, Rao, Rtc and Rpv) and a diode. Inertia of the blood in the aorta and
pulmonary artery are described by hydraulic inductances (Lav and Lpv, respectively).
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pulmonary artery are described by hydraulic inductances (Lav and Lpv, respectively) at
the exit of the ventricles. The model takes into account ventricular interaction by
means of the displacement of the septum, as it was found to have a significant impact
on the cardiovascular system dynamics [13,34-36].
Each cardiac chamber is described by its pressure (P) -volume (V) relationship and
provides volume and flow conditions around the physiological elements modelled by
the resistances. Both cardiac chambers describing the ventricles are active. The relation
linking the pressure to the volume is therefore not fixed and can be expressed by
means of a time varying elastance (E(t)), an intrinsic property of each active cardiac
chamber defined as:
E(t)=
P(t)
V(t)
(1)
This PV relationship varies between the PV relationships at the end of systole
(ESPVR) and at the end of diastole (EDPVR), as shown on Figure 2.
ESPVR : PES(V) = EES(V − Vd) (2)
EDPVR : PED(V) = P0(eλ(V−V0) − 1) (3)
Where PES is the end-systolic pressure, EES the end-systolic elastance, V the volume,
Vd the volume at zero pressure, PED the end-diastolic pressure and P0, l, V0 are three
parameters of the nonlinear relationship.
The transition between these two extremities is realised by several quasi-linear PV
relationships, the slope of which is given by the activation function, also named the
driver function, e(t) :
e(t)=
N 
i=1
Aie−Bi((tm o dD i)−Ci)
2
(4)
Figure 2 Overview of a pressure-volume loop stuck between the pressure-volume relationships at
the end of systole (ESPVR) and at the end of diastole (EDPVR).
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-2 ,
the delay C1 =0 . 2 7s and the duration of a cardiac cycle D1 =1 s,a sd e f i n e di nS m i t h
et al. [15]. Heart rate (HR beats/min) does not appear explicitly, but it is used to deter-
mine the value of one diver function parameter, D1 = 60/HR. This model doesn’tu s e
ECG data, but information relative to timing, delay and duration of the ventricular
contraction is contained in the driver function parameters. This activation function
accounts for myocardial activation and drives the changes in elastance. It varies
between 0 and 1.
Then, the pressure in the ventricle at any time t of a cardiac cycle is linked to the
volume by:
P(t)=e(t)×EES(V(t) − Vd)
+( 1− e(t))
× P0(eλ(V(t)−V0) − 1)
(5)
The 4 elastic cardiac chambers representing the major blood vessels are passive and
the pressure is assumed to be proportiona lt ot h ev o l u m eo ft h ec h a m b e r .T h ec o n -
stant ratio of P/V is denoted E and represents the so-called elastance of the chamber.
The behaviour of each chamber is characterised by the flow in and out of the cham-
ber (Qin, Qout), the pressure upstream and downstream (Pup, Pdown), the resistances of
the valves (Rin, Rout), and inertia of the blood (Lin, Lout) [13], yielding:
dV
dt
= Qin − Qout (6)
dQin
dt
=
Pup − P − QinRin
Lin
(7)
dQout
dt
=
Pdown − P − QoutRout
Lout
(8)
Equations 6 and 7 are solved when Qin > 0, during the filling stage, and Equations 6
and 8 are solved when Qout > 0, during the ejection stage. During the iso-metric
expansion and contraction phases, the model becomes much simpler, with volume and
pressure linked by Equation 5.
Four cardiac valves are located in the heart, at the entrance and the exit of each ven-
tricle. On Figure 1, these are represented by the electric symbol of a diode. Relations 7
and 8 describe the flows, but do not take into account the presence of valves regulating
the flow. Indeed, they allow backflow (i.e. a negative blood flow) in the system. The
physiological role of valves is exactly to prevent backflow by closing. To correctly
model the effect of the valves, a negative flow must be replaced by no flow. It can be
very simply modeled by replacing every appearance of a flow (Q) controlled by a valve
by (H(Q) Q), where the notation H denotes the function of Heaviside [14], defined by:
H(x)=

0 if x ≤ 0
1 if x > 0
(9)
The introduction of this H function allows to describe the “close on flow” property
[13,15] of the valve. To describe the “open on pressure” property [13,15], another H
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time when upstream pressure is higher than downstream pressure, until the time when
blood flow becomes negative. It is written. H((Pup - Pdown)+Q - 0.5).
Finally, the overall hemodynamic model reads the system of differential equations
(Equations 10 to 19):
dVpu
dt
= H(Qpul)Qpul − H(Qmt)Qmt (10)
dQmt
dt
= H(H(Ppu − Plv)+H(Qmt)
−0.5)
×

(1

Lmt)

(Ppu − Plv )
−Qmt Rmt)]
(11)
dVlv
dt
= H(Qmt)Qmt − H(Qav)Qav (12)
dQav
dt
= H(H(Plv − Pao)+H(Qav)
−0.5)
×

(1

Lav)

(Plv − Pao)
−Qav Rav)]
(13)
dVao
dt
= H(Qav)Qav − H(Qsys)Qsys (14)
dVvc
dt
= H(Qsys)Qsys − H(Qtc)Qtc (15)
dQtc
dt
= H(H(Pvc − Prv)+H(Qtc)
−0.5)
×

(1

Ltc)

(Pvc − Prv)
−Qtc Rtc)]
(16)
dVrv
dt
= H(Qtc)Qtc − H(Qpv)Qpv (17)
dQpv
dt
= H(H(Prv − Ppa)+H(Qpv)
−0.5)
×

(1

Lpv)

(Prv − Ppa)
−Qpv Rpv

(18)
dVpa
dt
= H(Qpv)Qpv − H(Qpul)Qpul (19)
Mitral valve model
T h em a i nd r a w b a c ko fu s i n gt h eH e a v i s i d efunctions to model the behaviour of the
valves, is that this cannot take into account the physiological time scale of valve
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valve dysfunctions.
As mentioned previously, an attempt to describe the progressive opening of the
mitral valve was made by Szabó et al. [12,26-28] to assess diastolic left ventricular
function based on Doppler velocity waveforms and cardiac geometry. The Szabó et al.
model of early ventricular filling [12,28] begins at the time of mitral valve opening,
when the pressures in the atrium and ventricle are equal and it describes the flow and
pressure during ventricular filling until the atrial systole. The input pressure difference
profile, ΔP(t), shown in Figure 3 was taken from measured animal data [37]. This pres-
sure difference was inferred from left atrial pressure (Pla) and left ventricular pressure
(Plv) profiles, measured invasively with catheters. The two peaks in valve opening
angle θ(t) evolution in Figure 3 refer to the E-wave and A-wave, which correspond to
the passive filling of the ventricle and the active filling resulting from atrial contraction,
respectively.
The main limitation of the mitral valve model by Szabó et al.i st h a ti ti so n l yv a l i d
during a small part of the cardiac cycle (the E-wave). To couple the mitral valve model
with the existing closed-loop CVS model, the model must be valid over a complete
cardiac cycle. However, the existing CVS model does not include a chamber for the
left atrium so it does not strictly capture atrial systole, also referred to as the A-wave
[13]. In this research, the mitral valve dynamics during the active filling phase is
assumed to be the same as during the passive filling phase so that all valvular para-
meters fixed by Szabo [12,28] are now used over the entire cardiac cycle. The A-wave
is therefore not modelled.
Figure 3 Animal data [37]showing measured Pla, Plv and theta, and the calculated ΔP. Pla and Plv
profiles were measured invasively with catheters. This animal data also consisted of distance
measurements of the amount the chords moved during a heartbeat, as measured by camera in a catheter
or endoscope. It was assumed the movement of the chords would reasonably correlate to the change in
opening angle, θ(t).
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be used to describe the dynamics of the mitral valve. The first equation describes the
flow rate through the mitral valve (Qmt). Thus, the corresponding equation from the
original CSV model has been modified to add a term that accounts for the variation in
the cross-sectional area of the mitral aperture. The differential equation then becomes:
Q·
mt =
Ppu − Plv
Lmt
− Qmt
Rmt
Lmt
+ Qmt
A˙ (t)
A(t)
(20)
Where:
Ppu = pulmonary veins pressure
Plv = left ventricular pressure
Qmt = instantaneous flow rate through the mitral valve
Rmt = mitral viscous resistance
Lmt = mitral inertance term
A = area of mitral valve aperture
The resistance and the inertance of the mitral valve, Rmt and Lmt, are defined to take
into account the existence of two states of the mitral valve (open and close). Therefore,
the “open on pressure, close on flow” law is no longer required in the equation defin-
ing the dynamics of transmitral blood flow. Thus, the H (H(Ppu - Plv)+H (Qmt) - 0.5)
and H (Qmt) factors can be removed from Equation 10, 11 and 12.
When the valve is open, Rmt, is low and when the valve is closed, the resistance is
infinitely high. Applying the definition of hydraulic resistance in a cylindrical flow to
this case [12] yields:
Rmt =
8πμl
A(t)
2 (21)
Similarly, the inertance is defined:
Lmt =
ρl
A(t)
(22)
Where r represents blood density in kg/m
3, l represents the blood column length
through the mitral valve in m and μ the viscosity in Ns/m
2.
The case A(t) ® 0 is numerically prevented working with (A(t)+ε) instead of A(t)i n
the numerical simulations, when it is needed to divide by A(t).
Dynamics of the mitral valve
The intrinsic dynamics of the valve must be able to describe all the modifications
applied that are not due to an outside force. Therefore, it depends on the mechanical
and geometrical properties of the valve, as well as on its composition. It is assumed
that intrinsic dynamics is governed by inertia, due to the mass and the size of leaflets,
by the elasticity of valvular tissues, and by the damping due to the blood surrounding
the leaflets. Szabo et al. proposed that variation of the effective area of the mitral valve
aperture can be defined by a second order differential equation [12,28] similar to that
defining the evolution of a linear damped oscillator.
In the presence of external forces, the dynamics becomes that of a forced oscillator.
These forces are mainly due to the pressure difference between both faces of the valve.
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valve closes, it places the surface (Amax - A) across the fluid flow, where Amax is the
maximal surface that the mitral aperture can reach.
The second order differential equation defining area of mitral valve aperture is written:
1
ω2
¨ A +
2D
ω
˙ A+A
=( Amax − A)
×

Ks(Ppu − Plv)

(23)
where D is the damping coefficient describing the amount of damping experienced
by the valve cusps, ω is the natural frequency of the valve, Amax is the maximal surface
that the mitral aperture can reach and KS is a coefficient introduced to adapt has the
dimension of right term.
This approach introduces two new state variables, A and ˙ A, and consequently two
new ordinary differential Equations 24 and 25.
dA
dt
= ˙ A (24)
d˙ A
dt
= ω2(Amax − A)

Ks(Ppu − Plv)

− 2D˙ Aω − Aω2
(25)
To ensure that A(t) remains positive, the two differential Equations 24 and 25 are
pre- multiplied by a Heaviside function: H{H(Ppu - Plv)+H(A) - 0.5}. The differential
equation is thus multiplied by zero when Ppu <Plv and A becomes zero, and variations
of A and ˙ A will be allowed when Ppu = Plv.
The resulting overall hemodynamic model reads now the system of differential equa-
tions (Equations 26 to 37):
dVpu
dt
= H(Qpul)Qpul − Qmt (26)
dQmt
dt
=

(1

Lmt)

(Ppu − Plv)
−Qmt Rmt)]
+(QmtA)
˙ A
(27)
dVlv
dt
= Qmt − H(Qav)Qav (28)
dQav
dt
= H(H(Plv − Pao)+H(Qav)
−0.5)
×

(1

Lav)( ( Plv − Pao)
−Qav Rav)

(29)
dVao
dt
= H(Qav)Qav − H(Qsys)Qsys (30)
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dt
= H(Qsys)Qsys − H(Qtc)Qtc (31)
dQtc
dt
= H(H(Pvc − Prv)+H(Qtc)
−0.5)
×

(1

Ltc)( ( Pvc − Prv)
−Qtc Rtc)

(32)
dVrv
dt
= H(Qtc)Qtc − H(Qpv)Qpv (33)
dQpv
dt
= H(H(Prv − Ppa)+H(Qpv)
−0.5)
×

(1

Lpv)( ( Prv − Ppa

−Qpv Rpv)

(34)
dVpa
dt
= H(Qpv)Qpv − H(Qpul)Qpul (35)
dA
dt
= H(H(Ppu − Plv)+H(A) − 0.5)˙ A (36)
d˙ A
dt
= H(H(Ppu − Plv)+H(A) − 0.5)
×

(Amax− A)ω2Ks(Ppu
−Plv) − 2D˙ Aω − A ω2
(37)
These differential equations are valid over the entire cardiac cycle. All other equa-
tions in the CVS model are unchanged.
Simulations of this resulting extended and physiologically multi-scale CVS model are
performed using a standard ODE solver in Matlab (The MathWorks, USA). Note that
this approach to describe the mitral valve can be generalized to other cardiac valves.
T h ep r e v i o u s l yv a l i d a t e dC V Sm o d e lw i t hHeaviside formulation and the new CVS
model with variable mitral valve effective area are simulated for a healthy human using
parameters from Tables 1, 2, 3 and 4.
Table 1 Base value of the pressure-volume relationship parameters used in the CSV
model (healthy heart)
Parameter (unit) Ees (mmHg/ml) Vd (ml) V0 (ml) l (1/ml) P0 (mmHg)
Left ventricle free wall (lvf) 2.8798 0 0 0.033 0.1203
Right ventricle free wall (rvf) 0.5850 0 0 0.023 0.2157
Septum free wall (spt) 48.7540 2.00 2.00 0.435 1.1101
Pericardium (pcd) - - 200.00 0.030 0.5003
Vena cava (vc) 0.0059 0 - - -
Pulmonary artery (pa) 0.3690 0 - - -
Pulmonary vein (pu) 0.0073 0 - - -
Aorta (ao) 0.0 0 - - -
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The closure and position of mitral leaflets are determined by the balance between two
forces acting on them: the closing forces generated by the LV systolic contraction
which effectively closes the valve, and the tethering forces that restrain the leaflets
avoiding leaflet prolapse. When tethering forces are increased by displacement of the
papillary muscles and the closure forces are reduced by LV dysfunction, the equili-
brium between these two forces is broken in favor of tethering forces with displace-
ment of the coaptation point of the leaflets in the ventricle, with a typical pattern of
incomplete mitral leaflet closure.
A valve presenting a closure defect due to a restricted motion of the papillary mus-
cles and whose leaflet structure is not affected, is considered to approach, at most, a
case of ischemic mitral insufficiency (IMI). Thus, the size and the shape of the mitral
leaflets do not change, and the parameters ω and D remain the same as in healthy
simulations. In contrast, Amax is increased to take into account the mitral annular
dilation [38] (Table 5). The closure defect (dc) observed consecutively to the displace-
ment of the papillary muscles attached to the leaflets of the valve is taken into account
in the Heaviside function that controls variations of A and ˙ A. The differential equa-
tions related to A and ˙ A (Equations 36 and 37) thus become:
dA
dt
= H{H(Ppu − Plv)+H(A − dc) − 0.5}
× ˙ A
(38)
d˙ A
dt
= H{H(Ppu − Plv)+H(A − dc) − 0.5}
×

ω2(Amax− A)Ks(Ppu
− Plv) − 2D˙ Aω − A ω2
(39)
Results and discussion
Before discussing simulations of IMI, we find need to validate our model. Given the
model assumptions, the main goal is to obtain a macroscopic behaviour similar to the
existing, previously validated CVS model. PV loops will be compared to evaluate over-
all accuracy in pressure and volume at the end of systole and the end of diastole.
A minimal error shows that the modified model matches the fundamental dynamics of
the clinically validated original CVS model.
Table 2 Base value of the resistance and inertance parameters used in the CSV model
Parameter (unit) R (mmHg s/ml) L (mmHg s
2/ml)
Mitral valve (mt) 0.0158 7.6968 × 10-5
Tricuspid valve (tc) 0.0237 8.0093 × 10-5
Aortic valve (av) 0.0180 1.2189 × 10-4
Pulmonary valve (pv) 0.0055 1.4868 × 10-4
Table 3 Base value of other parameters used in the CSV model
Parameter (unit) Value (unit)
Heart rate (HR) 60 (bpm)
Total blood volume (Vtot) 5.5 (l)
Thoracic cavity pressure (Pth) -4 (mmHg)
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T h ep r e v i o u s l yv a l i d a t e dC V Sm o d e lw i t hHeaviside formulation and the new CVS
model with variable mitral valve effective area are simulated for a healthy human using
parameters from Tables 1, 2, 3 and 4.
Figure 4 shows left ventricular PV loops and Figure 5, right ventricular PV loops of
both models. Both models give effectively identical results. The mean relative error in
P Vl o o p sa tt h ef o u rc o r n e r so ft h eP Vl o o p si s( 0m m H g ,0 . 0 0 0m l ) ,( - 0 . 0 1m m H g ,
1.176 ml), (0 mmHg, 0.130 ml) and (0 mmHg, 0 ml), which is within typical measure-
ment error and variability. These errors may also be due to computational differences.
While showing no global cardiac function difference, the new model provides a more
realistic description of the mitral valve. First, timing parameters are respected. In fact,
physiologically, the passive filling of the left ventricle is characterised by 3 crossovers
of pressures acting on both parts of the mitral valve. These 3 crossovers are critical for
the timing of mitral valve opening. The first is related to the opening time of the
mitral valve, the second to the maximum of the E-wave measured with Doppler and
the last one to the end of the E-wave [39]. Time between the first and the third cross-
over is the duration of the early ventricular filling, typically between 0.14s and 0.20s
depending of the heart state [12,37]. This period of early filling ends with the third
crossover and is followed by a diastasis phase during which pressures on both parts of
the valve remain very close, followed by atrial systole which leads to the active filling
of the left ventricle, measured as the A-wave. The ventricle then starts to contract,
driving ventricular pressure higher than atrial pressure, closing the mitral valve. Thus,
the mitral valve remains open during about 0.27s to 0.32s [37].
Parameters of the mitral valve model have been chosen to fit opening and closing
times. So even if all of pressure crossovers can’t be found in the pressure evolution dia-
gram (Figure 6), opening time, maximum opening of the early ventricular filling time
and closing time are respected. In fact, mitral valve opens at time t = 0.589s, reaches its
maximum at t = 0.666s and closes at time t = 0.921s as shown in Figure 7 which shows
the evolution of mitral valve aperture area for the previous model with “open on pres-
sure, close on flow” law for the mitral valve dynamics and for the new model. It means
that mitral valve remains open during 0.3320s which is close to physiological values [37].
Table 4 Base value of parameters used in the mitral valve model (healthy mitral valve)
Parameter (unit) Value (unit)
Static gain factor (Ks) 0.05 (1/mmHg)
Maximal mitral valve area (Amax) 1.1 (cm
2)
Eigen frequency (ω) 30(rad/s)
Damping factor (D) 10 (1/rad)
Table 5 Base value of parameters used in the mitral valve model (mitral insufficiency)
Parameter (unit) value
Static gain factor (Ks) 0.05 (1/mmHg)
Maximal mitral valve area (Amax) 1.3 (cm
2)
Eigen frequency (ω) 30 (rad/s)
Damping factor (D) 10 (1/rad)
Defect of closure (dc) 0.2 (cm
2)
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Page 12 of 20Figure 4 Simulated left ventricular pressure-volume loops for a healthy valve. Blue dotted: previously
validated model, red linear: new model. Emphasis on the resemblance of the results in term of global
behavior of the heart.
Figure 5 Simulated right ventricular pressure-volume loops for a healthy valve. Blue dotted:
previously validated model, red linear: new model. Emphasis on the resemblance of the results in term of
global behavior of the heart.
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Page 13 of 20Figure 6 Simulated pressure evolution on both sides of the mitral valve (Ppu and Plv) for a healthy
valve. Blue: previously validated model, red: new model. Emphasis on the 2 pressure crossovers.
Figure 7 Simulated mitral valve aperture area evolution for a healthy valve. Blue dotted: previously
validated model, red linear: new model. Emphasis on the differences between opening valve profiles.
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Page 14 of 20The time of maximum opening of the early ventricular filling is reached 0.077s after the
mitral valve opens while this time is about 71 to 96 ms in literature [39], depending on
the location of the measurement.
Figure 8 shows the evolution of transmitral blood flow during one cardiac cycle for
the previous model with “open on pressure, close on flow” law for the mitral valve
dynamics and for the new model. The maximum is reached at maximum mitral valve
opening, and corresponds to a flow of 569.7 ml/s close to the 450 to 550 ml/s expected
physiologically [40]. The value simulated is higher than the one found in literature
because we only consider passive filling.
Application to IMI
A physiologically evolution of mitral flow and mitral valve opening area during the
early diastolic filling are needed to validate the updated model in dysfunction. In parti-
cular, the time of closure of the mitral valve is assessed to ensure proper closing time.
Its change with dysfunction is also compared to clinical expectations. The specific dys-
function here modelled is mitral insufficiency consecutive to myocardial infarction and
ventricular remodelling.
The loss of any portion of viable myocardium following myocardial infarction
decreases the pumping ability of the heart, which is reflected in a deterioration of car-
diac function. Postinfarction remodeling of the myocardium occurs to maintain cardiac
output. These changes in the structure of the left ventricle alters the geometrical rela-
tionship between the ventricle and valve appartus generating a restricted leaflet motion
termed incomplete mitral leaflet closure (IMLC) [38,41]. To model these changes,
EESLVF (end systolic elastance of the left ventricle) is reduced by half, while VdLVF
Figure 8 Simulated transmitral flow evolution for a healthy valve. Blue dotted: previously validated
model, red linear: new model. Emphasis on the differences between flow profiles.
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Page 15 of 20(dead volume of the left ventricle) and V0LVF (initial volume of the left ventricle) are
first doubled and then gradually reduced to their initial values mimicking the experi-
mental work of Shioura et al. [42].
Realistic acute mitral valve regurgitation due to a permanent defect of closure
(Tables 2, 3, 5 and 6) was simulated. Figure 9 shows the evolution of mitral valve aper-
ture area over a cardiac cycle evidencing the permanent opening of the mitral valve.
Figure 10 shows the left PV loops for a healthy heart versus a remodelled heart with
IMI. Left PV loops for the diseased heart are qualitatively similar to those observed
experimentally [42] and clinically [1]. In fact, Raff and colleagues [1] have shown that
pressure-volume loops are modified in the presence of valvular dysfunction and more
specifically, that a global increase in ventricular volume is observed (PV loops move
towards the right), as well as an increase in stroke volume. In Figure 10, minimal
ventricular volume passes from 47.47 ml for the simulation of the healthy valve to
83.20 ml for the simulation of the incompetent valve while stroke volume passes from
79.43 ml to 92.80 ml. Raff et al. [1] also evidenced the disappearance of isovolumetric
phases, isovolumetric contraction and isovolumetric relaxation. Figure 10 shows that
these 2 phases have also disappeared because the mitral valve remains at least partly
open during the entire cardiac cycle. In fact, when the ventricle contracts, some blood
goes backward from the ventricle to the pulmonary veins chamber in the model result-
ing in negative transmitral flow, as shown in Figure 11, reducing the amount of blood
at the end of the contraction just before the aortic valve opens.
Our results thus prove that our simple model can capture both the healthy state and
valvular incompetence due to a defect in closure with appropriate variable changes.
Limitations
While these results show strong physiological correlation to independently measured
data, the second order model used to model the mitral valve aperture dynamics is not
completely physiologically relevant. Specifically, the terms in the Equation 39 do not
relate directly to the observed anatomical structure and function of the valve. Hence,
the model itself, while capturing the effective dynamics, can provide no insight into
specific disease impact or damage that results in valve dysfunction, even though it can
model that dysfunction.
While we could compare pressure and flow curves, the measurement of the variable
mitral valve area was not possible. To our best knowledge, no such data have been
published for humans or pigs until recently. Using the newest developments in
Table 6 Base value of the pressure-volume relationship parameters used in the CSV
model (heart remodeled after ischemic event)
Parameter (unit) Ees (mmHg/ml) Vd (ml) V0 (ml) l (1/ml) P0 (mmHg)
Left ventricle free wall (lvf) 1.4399 30 20 0.023 0.1203
Right ventricle free wall (rvf) 0.5850 0 0 0.023 0.2157
Septum free wall (spt) 48.7540 2.00 2.00 0.435 1.1101
Pericardium (pcd) - - 200.00 0.030 0.5003
Vena cava (vc) 0.0059 0 - - -
Pulmonary artery (pa) 0.3690 0 - - -
Pulmonary vein (pu) 0.0073 0 - - -
Aorta (ao) 0.0 0 - - -
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Page 16 of 20Figure 9 Simulated mitral valve aperture area evolution for a healthy heart versus a remodelled
heart with an ischemic mitral regurgitation. Blue dotted: new model simulated for a healthy heart, red
linear: new model simulated for a remodelled heart with an ischemic mitral regurgitation. Emphasis on the
differences between healthy and diseased profiles, and the remaining opening of the diseased valve.
Figure 10 Simulated left ventricular pressure-volume loops for a healthy heart versus a remodelled
heart with an ischemic mitral regurgitation. Blue dotted: new model simulated for a healthy heart, red
linear: new model simulated for a remodelled heart with an ischemic mitral regurgitation. Emphasis on the
differences of the results in term of global behaviour of the heart.
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Page 17 of 20magnetic resonance technology and 4-dimensional echocardiography the authors are
currently involved in a study to determine t h et i m ec o u r s eo fm i t r a lv a l v eo p e n i n g .
Even if we were not able to measure variable mitral valve area, the very good agree-
ment between measured and calculated pressure and flow curves indicates that the
simulated curves of mitral valve opening should be close to the natural time course.
In this model atrial contraction is not included. Further work will be needed to
extend this model to include atrial systole and, to be able to model physiologically late
diastolic filling. However, this limitation is not central to determine the efficiency of a
refined mitral valve model, although some results in timing may be affected. This
improvement would also widen the number of types of mitral insufficiencies that could
be simulated. As noted before it would also enable a better assessment of timing pro-
blems due to a bad delay between atrial and ventricular contraction.
Conclusions
This work describes a new multi-scale closed-loop physiological model of the cardio-
vascular system that accounts for progressive mitral valve motion. Simulations show
that expected trends are respected for healthy and diseased valve states. These results
suggest a further use of this model to track, diagnose and control valvular pathologies.
The large number of valve model parameters indicates a need for new minimal and
more physiologically relevant mitral valve models that are readily identifiable to achieve
maximum benefit in real-time use of such models. However, the overall approach and
modelling framework are readily generalisable to both other valves and more relevant
valve models, proving the overall concept and approach.
Figure 11 Simulated transmitral flow evolution for a healthy heart versus a remodelled heart with
an ischemic mitral regurgitation. Red dotted: new model simulated for a healthy heart, blue linear: new
model simulated for a remodelled heart with an ischemic mitral regurgitation. Emphasis on the backflow
(negative flow) for the diseased profile.
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